Background. Malignant hyperthermia (MH) is a potentially lethal disease triggered by volatile anaesthetics and succinylcholine in genetically predisposed individuals. Because of the heterogenetic nature of MH, a simple genetic-based diagnostic test is not feasible and diagnosis requires an invasive open muscle biopsy followed by the in vitro contracture test (IVCT). Our aim was to establish if measurements of halothane-induced increases in intracellular calcium ion concentration [Ca 2+ ] i in cultured human skeletal muscle cells can be used to phenotype MH susceptibility and if different mutations in the ryanodine receptor (RYR1) gene affect halothane-induced increases in [Ca 2+ ] i .
European MH Group, patients are then diagnosed as MHS or MH negative (MHN) on the basis of contractile threshold and sensitivity of the muscle bundles to halothane and caffeine. If contracture is achieved only with either caffeine or halothane, the patient is diagnosed as MH equivocal (MHE). 6 9 The underlying cause of MH is an abnormality in skeletal muscle calcium metabolism. 10 11 Therefore, alterations in proteins involved in the regulation of the intracellular calcium concentration ([Ca 2+ ] i ), such as the calcium pump, the calcium release channel or other proteins implicated in excitation±contraction coupling, could potentially cause Table 1 Family of origin (a capital letter indicates members belonging to the same family, the absence of a letter indicates single members of a family), identi®cation of malignant hyperthermia (MH)-linked ryanodine receptor (RYR1) mutation and in vitro contracture test (IVCT) of muscle biopsies. MHN=MH negative; MHS=MH susceptible; MHE=MH equivocal 
Patient selection
We selected 54 patients from 26 families with a positive history of MH without clinical signs of neuromuscular disease. The age range of the patients was 8±59 yr. Twentytwo patients were diagnosed as MHS, 18 as MHN and 14 as MHE by IVCT. Patients were classi®ed as MHS if a contracture force b0.2 g was elicited by at least 2% halothane and 2 mM caffeine, as MHE if a contracture force b0.2 g was elicited only by either caffeine or halothane, and MHN if contractures b0.2 g were not reached with either trigger agent. The characteristics of the individuals involved in this study, including contractures obtained from the muscle strips during the IVCT, family of origin and mutation found are given in Table 1 .
The protocol for the study was approved by the University of Basel Hospital Ethics Committee and written informed consent was obtained from patients.
Materials
Dulbecco modi®ed Eagle (DME) medium containing 4.5 mg ml ±1 glucose, fetal calf serum (FCS), horse serum, penicillin G and streptomycin was purchased from Life Technologies Ltd, Paisley, UK. Insulin was purchased from Eli Lilly and Co., Indianapolis, IN, USA. Cell culture material was from Becton Dickinson GmbH, Heidelberg, Germany. Halothane was from Halocarbon Labs, Inc., Hackensack, NJ, USA. The mammalian blood DNA isolation kit and Taq polymerase and DNA restriction enzymes were from Roche Molecular Biochemicals (Basel, Switzerland). The kit for DNA isolation from tissue was from Machery-Nagel GmbH, Du Èren, Germany. The polymerase chain reaction (PCR) puri®cation kit was from Qiagen GmbH, Hilden, Germany. Fura-2/AM and ionomycin were from Sigma Chemical Co., St Louis, MO, USA. Primers were from Microsynth GmbH, Balgach, 
Human skeletal muscle cell cultures
Primary human muscle cell cultures were established from surplus fragments taken from biopsies of patients undergoing diagnostic IVCT as described previously. 17 Cells were grown in DME, 10% horse serum, insulin 5 ng ml ±1 , 2 mM glutamine, antibiotics and 7 mM HEPES, pH 7.4 (proliferative medium) under standard cell culture conditions. For cryopreservation, about 10 6 cells were resuspended in DME containing 40% FCS and 10% DMSO and were stored in liquid nitrogen.
[Ca 2+ ] i measurements
For measurements of [Ca 2+ ] i , cells were trypsinized and transferred from tissue culture¯asks to glass coverslips and allowed to grow in proliferative medium until groups of cells were visible. We have previously demonstrated that under these culture conditions the cells acquire skeletalmuscle-speci®c proteins such as sarcomeric a-actinin and type-1 RYR, 17 although they do not fully differentiate into multinuclear myotubes. Such primary cultures exhibit a degree of variability in the maturity of individual cells.
Cells to be tested were loaded with the¯uorescent calcium indicator fura-2/AM. Single-cell calcium measurements using¯uorescence microscopy were performed on 10 cells before and after the addition of halothane. A new coverslip containing fura-2/AM-loaded cells was used for each halothane concentration. For each experiment a total of 72 digital images were recorded at excitations of 340 and 380 nm and the ratio calculated, as per our previous study. 17 The values obtained during the ®rst 10 cells (i.e. before the application of halothane) were used to calculate the resting [Ca 2+ ] i . Values were then taken during halothane perfusion as well as after addition of EGTA/ionomycin and calcium ions to obtain R min (the value obtained in the presence of EGTA) and R max (the value obtained in the presence of high calcium after the addition of ionomycin). Each run lasted approximately 6 min, including the time taken to run the calibration at the end of the experiment. Halothane in DMSO was administered at the indicated concentrations from a gas-tight vial by means of a roller pump. Its actual concentration was veri®ed by gas chromatography in several test runs using ®xed¯ow rates, temperature and tubing. Calibration was performed using the EGTA/ ionomycin/manganese chloride method. 18 The changes in uorescence were converted into [ 
Mutation screening
Screening for the presence of nine of the most frequent MHlinked mutations (Arg163Cys, Gly341Arg, Arg614Cys, Arg614Leu, Arg2163Cys, Val2168Met, Gly2434Arg, Arg2458Cys, Arg2458His) was performed by genomic DNA PCR ampli®cation followed by restriction enzyme digestion and polyacrylamide gel electrophoresis. Total genomic DNA was isolated from either peripheral blood or muscle fragments not used for IVCT. PCR conditions and primer sequences were as described previously. 19 
Statistical analysis
The [Ca 2+ ] i measurements from the three diagnostic groups were compared using repeated measurements ANOVA. Within each halothane concentration, the results from the three diagnostic groups were compared using Fishers's protected least signi®cant difference (PLSD) post-hoc test.
To Figure 1 ). In addition, the increases in [Ca 2+ ] i in muscle cells from MHS and MHE individuals were shifted to lower halothane concentrations when compared with cells from MHN individuals (P<0.0001; repeated measurements ANOVA, Figure 1 ). Fisher's PLSD post-hoc test revealed signi®cant differences (P<0.001) between all ] i is particularly evident at halothane concentrations b5.7 mM and was irrespective of the mutation.
The halothane`trigger concentration' appears to vary between individuals with different mutations. 19 21 In order to study if this is speci®c for a given mutation or a more general phenomenon, we analysed the halothane-induced peak [Ca 2+ ] i in cells obtained from unrelated individuals carrying the same Val2168Met mutation. Halothane trigger concentrations and peak [Ca 2+ ] i were different in these unrelated individuals (Fig. 4) , suggesting that the genetic background in¯uences the halothane-induced increase in [Ca 2+ ] i .
Discussion
In the present report we show that halothane-induced increases in [Ca 2+ ] i in human skeletal muscle cells can be used to phenotype MH susceptibility. However, our results
show In this study we con®rm and extend our previous results. In fact, our earlier work was based on observations carried out on two MHS subjects and three MHN subjects while in this study we also included 14 MHE individuals, and the number of patients involved was 10 times larger. In the study by Censier and colleagues, 17 we observed that the maximum difference between MHS and MHN, as far as halothane-induced increases in [Ca 2+ ] i are concerned, occurred at halothane concentrations of 5.7±9.5 mM. In addition, we con®rm that the mean increase in [Ca 2+ ] i of cells from MHN individuals occurring at 8.6 mM halothane is similar to that of cells from MHS individuals at 5.7 mM halothane (203 nM vs 167 nM, respectively; P=0.269, student's t-test for unpaired samples).
The response of cells presented in our previous report 17 seem to be different from those found in this study. In the present study we examined a larger sample than previously and we believe that the values obtained are more likely to represent the MHN population. We would like to point out that it is very important to perform [Ca 2+ ] i measurements at several halothane concentrations and we suggest concentrations ranging around 5.7 mM since this is the concentration where maximal differences can be observed. Calcium measurements for phenotyping MH In this study we used small fragments of tissue (2±4 mm 3 ) left over from muscle biopsies. We have already assessed the feasibility of obtaining primary cultures from needle biopsies (unpublished observations). This approach offers obvious physical advantages for the patients, as well as being cheaper. Obviously there are some limitations in the use of this novel approach: (i) the need for cell culture and uorescent calcium imaging facilities, (ii) the fact that cells cultured from the biopsies give rise to heterogeneous cell populations that do not respond to halothane in a uniform way, (iii) not all individuals diagnosed as MHS by IVCT had an halothane-induced increase in [Ca 2+ ] i beyond that of the MHN population.
As to the future of MH diagnostics, one can envisage that individuals from families with de®ned mutations could ®rst undergo genetic testing. 22 If no mutation is found, they could undergo a skeletal muscle needle biopsy followed by measurements of halothane-induced increases in [Ca 2+ ] i . If measurements of [Ca 2+ ] i do not reveal MH susceptibility, then an IVCT could be performed. With this less invasive and stepwise approach, the high sensitivity of the IVCT and thus the high safety level of MH diagnostics is maintained. In fact if these criteria were used, only three of the 22 MHS individuals and seven of the 14 MHE individuals would still require the invasive IVCT. For the time being, however, all the MHN individuals would still require IVCT testing.
The common ®nal pathway for MH is the loss of the ®ne regulation of calcium homeostasis in muscle cells. The present investigation is not only potentially important from a clinical point of view, but also from a biological one. In fact, it indicates that although a variety of factors such as metabolic processes, muscle training, protein composition and enzyme activation may in¯uence the IVCT (at least as far as contracture force is concerned), there is an intrinsic defect' in the machinery involved in [Ca 2+ ] i homeostasis in MHS individuals. Each individual may compensate for the molecular defect in a variety of ways, which may be in¯uenced by the speci®c mutation present as well as other genetic and`environmental' factors. This hypothesis is supported by the fact that the halothane-induced changes in [Ca 2+ ] i in cells from MHS individuals bearing the same point mutation but with a different genetic background do not coincide, and because MHS individuals with RYR1 mutations do not undergo MHS reactions at every contact with trigger agents. 4 5 Our results also show that the penetrance of a given mutation varies between individuals. This observation would be expected in view of the fact that the RYR must assemble as a tetramer in order to function as a calcium channel. The results of this study, as well as data from IVCT, tend to favour the hypothesis that mutated channels are probably randomly distributed, giving rise tò heterogeneous' responses, but the presence of a single mutated channel is suf®cient to confer the MHS phenotype. This hypothesis is supported by our previous work, 17 in which the normal phenotype was not reconstituted by transfecting MHS cells with wild-type channels.
In conclusion, measurements of [Ca 2+ ] i may be useful in increasing the accuracy of MH phenotyping and may therefore be used as a complementary method for the diagnosis of MH susceptibility.
